The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Toxicities with combination BRAF and MEK inhibition in resected stage III melanoma.
 
Govind Warrier
No Relationships to Disclose
 
Morgan Homan
No Relationships to Disclose
 
Christopher D. Lao
Consulting or Advisory Role - Bristol-Myers Squibb; Immunocore
Research Funding - Bristol-Myers Squibb; Dynavax Technologies; Genentech; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Immunocore
 
Sarah Elizabeth Yentz
No Relationships to Disclose
 
Shawna Kraft
No Relationships to Disclose
 
Leslie Anne Fecher
Consulting or Advisory Role - Elsevier; Hoosier Cancer Research Network; Via Oncology
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Kartos Therapeutics (Inst); Merck (Inst); Pfizer/EMD Serono (Inst)
(OPTIONAL) Uncompensated Relationships - NCCN